Gabaergic receptor subtype selective ligands and their uses

Cook, J. M., Clayton, T. S., Jain, H. D., Johnson, Y. T., Yang, J., Rallipalli, S. K., Wang, Z., Namjoshi, O. A., & Poe, M. M. (2015). Gabaergic receptor subtype selective ligands and their uses. (U.S. Patent No. US20150258128A1). https://patents.google.com/patent/US20150258128A1/en?oq=Cook%2c+J.+M.%2c+Clayton%2c+T.+S.%2c+Jain%2c+H.+D.%2c+Rallapalli%2c+S.%2c+Johnson%2c+Y.-T.%2c+Poe%2c+M.%2c+Namjoshi%2c+O.+A.%2c+%26+Wang%2c+Z.-J.+(2015).+Gabaergic+receptor+subtype+selective+ligands+and+their+uses.+U.S.+Patent+number+US2015%2f0258128A1.+Filed+March+03%2c+2015;+published+September+17%2c+2015

Abstract

Described herein are α3 or α2 or α2/α3 GABAergic receptor subtype selective ligands, pharmaceutical compositions, and methods of use of such ligands and compositions in treatment of anxiety disorders, epilepsy and schizophrenia with reduced sedative and ataxic side effects. In embodiments, such as α3 or α2 or α2/α3 GABAergic receptor subtype selective ligands lack ester linkages and may be thus relatively insensitive to hydrolysis by esterases.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Does the relationship between alcohol retail environment and alcohol outcomes vary by depressive symptoms? Findings from a US Survey of Black, Hispanic and White drinkers
Article

Internalizing and externalizing subtypes of alcohol misuse and their relation to drinking motives
Article

What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders
Article

Grandi Byen-supporting child growth and development through integrated, responsive parenting, nutrition and hygiene